Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Cytokine ; 14(2): 97-103, 2001 Apr 21.
Artigo em Inglês | MEDLINE | ID: mdl-11356010

RESUMO

Leptin, an appetite-regulating hormone/cytokine, circulates both free and bound to soluble leptin receptors (s-leptin R). An electrochemiluminescence (ECL) assay for the quantitative measurement of murine s-leptin R was developed. The absence of s-leptin R immunoreactivity in the serum of db(pas)/db(pas)mice demonstrated the specificity of the assay, which detected s-leptin R both in the free form and complexed with leptin. The distribution of free vs bound leptin and the regulation of s-leptin R were evaluated in mice following administration of the pro-inflammatory stimuli endotoxin (100 microg/mouse) and turpentine (100 microl/mouse). Both endotoxin and turpentine significantly increased serum leptin and s-leptin R levels compared to control mice. The distribution of free vs bound leptin was not altered by administration of endotoxin or turpentine. In fact, approximately 50% of total leptin was present in the free form in either control, endotoxin- or turpentine-injected mice. On the contrary, during the hyperleptinemia of pregnancy, only 10% of total leptin was present in the free form. We conclude that inflammation leads to the increase of both bound and free leptin. Therefore, the total amount of bioactive leptin is increased during acute inflammation, suggesting that leptin participates in the host response to inflammation.


Assuntos
Proteínas de Transporte/metabolismo , Inflamação/metabolismo , Leptina/metabolismo , Receptores de Superfície Celular , Animais , Cromatografia em Gel , Eletroquímica , Feminino , Inflamação/induzido quimicamente , Leptina/sangue , Lipopolissacarídeos/farmacologia , Medições Luminescentes , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Mutantes , Obesidade/genética , Obesidade/metabolismo , Gravidez/metabolismo , Receptores para Leptina , Solubilidade , Magreza/metabolismo , Terebintina/farmacologia
2.
J Biol Chem ; 275(51): 40036-41, 2000 Dec 22.
Artigo em Inglês | MEDLINE | ID: mdl-10998416

RESUMO

During the course of a study aimed at isolating transcripts specifically or preferentially expressed in the inner ear, we identified a novel gene, encoding a fibrocyte-derived protein, that we named Fdp. Fdp is predicted to be a secreted 128-amino acid protein, which is highly homologous to the melanoma-inhibiting activity/cartilage-derived retinoic acid-sensitive protein (MIA/CD-RAP), a cartilage-specific protein also expressed in several tumors. Fdp and MIA/CD-RAP thus define a new family of proteins. Fdp is expressed from embryonic day 10.5 in the mesenchyme surrounding the otic epithelium. During development, these cells progressively aggregate, condense, and differentiate into cartilaginous cells forming the otic capsule, which no longer expresses Fdp, and into fibrocytes surrounding the epithelia, which strongly express Fdp. In order to address the function of Fdp, we developed an in vitro antisense oligonucleotide approach using microdissected periotic mesenchyme micromass cultures, and showed that Fdp antisense oligonucleotide treatment results in a significant reduction in chondrogenesis. Our results demonstrate that Fdp plays a role in the initiation of periotic mesenchyme chondrogenesis. Accordingly, Fdp and its human ortholog FDP, which map to chromosome 2 and band 20p11, respectively, could be candidate genes for forms of deafness associated with malformations of the otic capsule.


Assuntos
Diferenciação Celular/fisiologia , Orelha Interna/citologia , Proteínas/fisiologia , Sequência de Aminoácidos , Sequência de Bases , DNA Complementar , Orelha Interna/efeitos dos fármacos , Dados de Sequência Molecular , Oligonucleotídeos Antissenso/farmacologia , Proteínas/química , Proteínas/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Homologia de Sequência de Aminoácidos
3.
Nat Genet ; 25(4): 440-3, 2000 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-10932191

RESUMO

As the human genome project approaches completion, the challenge for mammalian geneticists is to develop approaches for the systematic determination of mammalian gene function. Mouse mutagenesis will be a key element of studies of gene function. Phenotype-driven approaches using the chemical mutagen ethylnitrosourea (ENU) represent a potentially efficient route for the generation of large numbers of mutant mice that can be screened for novel phenotypes. The advantage of this approach is that, in assessing gene function, no a priori assumptions are made about the genes involved in any pathway. Phenotype-driven mutagenesis is thus an effective method for the identification of novel genes and pathways. We have undertaken a genome-wide, phenotype-driven screen for dominant mutations in the mouse. We generated and screened over 26,000 mice, and recovered some 500 new mouse mutants. Our work, along with the programme reported in the accompanying paper, has led to a substantial increase in the mouse mutant resource and represents a first step towards systematic studies of gene function in mammalian genetics.


Assuntos
Genes/fisiologia , Genoma , Mutagênese/genética , Animais , Animais Recém-Nascidos , Mapeamento Cromossômico , Cruzamentos Genéticos , Criopreservação , Etilnitrosoureia/farmacologia , Feminino , Fertilização in vitro , Genes/efeitos dos fármacos , Genes/genética , Testes Hematológicos , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C3H , Atividade Motora/genética , Mutagênese/efeitos dos fármacos , Mutagênicos/farmacologia , Mutação , Fenótipo , Fatores de Tempo , Desmame
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...